Study is on haemoglobin accuracy, reliability and precision using the I-Stat point of care device.

Phase 4

• Conditions: Massive blood loss in surgery; Surgery - Other surgery

• Registration Number: ACTRN12606000528550
• Lead Sponsor: Dr Wai Leap Ng

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2006-12-21
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Surgery involving total blood loss of 25%.

Exclusion Criteria

1) paitents with hypoalbuminaemia2) patients transfused with albumin.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
I-Stat Haemoglobin [Measured at start of surgery, 25 & 40% blood volume loss. The duplicated measurements are taken at the same time points; 25 & 40% blood loss.]

Secondary Outcome Measures

Name	Time	Method
aboratory haemoglobin[Measured at start of surgery, 25 & 40% blood volume loss. ];Laboratory and I-Stat plasma proteins[Measured at the following time points; induction of anaesthesia, when 25% blood loss is reached and when 40% blood loss is reached.];The duplicated I-Stat measurements[Taken at the same time points; when 25% blood loss is reached and when 40% blood loss is reached.]